dev.rsna.org/media/pressreleases/pr_target.cfm?ID=358 -
[Cached Version]
Published on: 3/25/2008
Last Visited: 9/28/2009
"This is the first study to show that MRI detection and measurement of the spread of prostate cancer outside the capsule of the prostate is an important factor in determining outcome for men scheduled to undergo radiation therapy," said study co-author Fergus V. Coakley, M.D., professor of radiology and urology, vice chair for clinical services and section chief of abdominal imaging in the Department of Radiology at University of California, San Francisco.
...
Dr. Coakley and colleagues sought to determine if MRI findings prior to radiation therapy were an indicator of possible recurrence and spread.
...
"Patients with substantial extracapsular spread of prostate cancer may wish to discuss options for more aggressive therapy with their treating physicians," Dr. Coakley said.
# # #
"Prostate Cancer: Role of Pretreatment MR in Predicting Outcome after External-Beam Radiation Therapy-Initial Experience.
Collaborating with Dr. Coakley were David A. McKenna, M.B., B.Ch., Antonio C. Westphalen, M.D., Shoujun Zhao, Ph.D., Ying Lu, Ph.D., Emily M. Webb, M.D., Barby Pickett, M.Sc., Mack Roach III, M.D., and John Kurhanewicz, Ph.D. Journal attribution requested.